Copyright Reports & Markets. All rights reserved.

Global Transdermal Testosterone Market Professional Survey Report 2019

Request for Sample of this report
Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Transdermal Testosterone Industry
  • 1.7 COVID-19 Impact: Transdermal Testosterone Market Trends

    • 2 Global Transdermal Testosterone Quarterly Market Size Analysis

    • 2.1 Transdermal Testosterone Business Impact Assessment - COVID-19
      • 2.1.1 Global Transdermal Testosterone Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
      • 2.1.2 Global Transdermal Testosterone Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Transdermal Testosterone Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 Global Transdermal Testosterone Quarterly Market Size by Manufacturers, 2019 VS 2020
    • 3.2 Global Transdermal Testosterone Factory Price by Manufacturers
    • 3.3 Location of Key Manufacturers Transdermal Testosterone Manufacturing Factories and Area Served
    • 3.4 Date of Key Manufacturers Enter into Transdermal Testosterone Market
    • 3.5 Key Manufacturers Transdermal Testosterone Product Offered
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Transdermal Testosterone Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Gel
      • 1.4.2 Patch
      • 1.4.3 Solution
    • 4.2 By Type, Global Transdermal Testosterone Market Size, 2019-2021
      • 4.2.1 By Type, Global Transdermal Testosterone Market Size by Type, 2020-2021
      • 4.2.2 By Type, Global Transdermal Testosterone Price, 2020-2021

    5 Impact of Covid-19 on Transdermal Testosterone Segments, By Application

    • 5.1 Overview
      • 5.5.1 Primary hypogonadism
      • 5.5.2 Hypogonadotropic hypogonadism
      • 5.5.3 Late-onset hypogonadism
    • 5.2 By Application, Global Transdermal Testosterone Market Size, 2019-2021
      • 5.2.1 By Application, Global Transdermal Testosterone Market Size by Application, 2019-2021
      • 5.2.2 By Application, Global Transdermal Testosterone Price, 2020-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 AbbVie
      • 7.1.1 AbbVie Business Overview
      • 7.1.2 AbbVie Transdermal Testosterone Quarterly Production and Revenue, 2020
      • 7.1.3 AbbVie Transdermal Testosterone Product Introduction
      • 7.1.4 AbbVie Response to COVID-19 and Related Developments
    • 7.2 Teva
      • 7.2.1 Teva Business Overview
      • 7.2.2 Teva Transdermal Testosterone Quarterly Production and Revenue, 2020
      • 7.2.3 Teva Transdermal Testosterone Product Introduction
      • 7.2.4 Teva Response to COVID-19 and Related Developments
    • 7.3 Perrigo
      • 7.3.1 Perrigo Business Overview
      • 7.3.2 Perrigo Transdermal Testosterone Quarterly Production and Revenue, 2020
      • 7.3.3 Perrigo Transdermal Testosterone Product Introduction
      • 7.3.4 Perrigo Response to COVID-19 and Related Developments
    • 7.4 Endo Pharmaceuticals
      • 7.4.1 Endo Pharmaceuticals Business Overview
      • 7.4.2 Endo Pharmaceuticals Transdermal Testosterone Quarterly Production and Revenue, 2020
      • 7.4.3 Endo Pharmaceuticals Transdermal Testosterone Product Introduction
      • 7.4.4 Endo Pharmaceuticals Response to COVID-19 and Related Developments
    • 7.5 Acerus Pharmaceuticals
      • 7.5.1 Acerus Pharmaceuticals Business Overview
      • 7.5.2 Acerus Pharmaceuticals Transdermal Testosterone Quarterly Production and Revenue, 2020
      • 7.5.3 Acerus Pharmaceuticals Transdermal Testosterone Product Introduction
      • 7.5.4 Acerus Pharmaceuticals Response to COVID-19 and Related Developments
    • 7.6 Lupin
      • 7.6.1 Lupin Business Overview
      • 7.6.2 Lupin Transdermal Testosterone Quarterly Production and Revenue, 2020
      • 7.6.3 Lupin Transdermal Testosterone Product Introduction
      • 7.6.4 Lupin Response to COVID-19 and Related Developments
    • 7.7 Dr. Reddy's Laboratories
      • 7.7.1 Dr. Reddy's Laboratories Business Overview
      • 7.7.2 Dr. Reddy's Laboratories Transdermal Testosterone Quarterly Production and Revenue, 2020
      • 7.7.3 Dr. Reddy's Laboratories Transdermal Testosterone Product Introduction
      • 7.7.4 Dr. Reddy's Laboratories Response to COVID-19 and Related Developments
    • 7.8 Upsher-Smith Laboratories
      • 7.8.1 Upsher-Smith Laboratories Business Overview
      • 7.8.2 Upsher-Smith Laboratories Transdermal Testosterone Quarterly Production and Revenue, 2020
      • 7.8.3 Upsher-Smith Laboratories Transdermal Testosterone Product Introduction
      • 7.8.4 Upsher-Smith Laboratories Response to COVID-19 and Related Developments
    • 7.9 Allergan
      • 7.9.1 Allergan Business Overview
      • 7.9.2 Allergan Transdermal Testosterone Quarterly Production and Revenue, 2020
      • 7.9.3 Allergan Transdermal Testosterone Product Introduction
      • 7.9.4 Allergan Response to COVID-19 and Related Developments
    • 7.10 Cipla Inc.
      • 7.10.1 Cipla Inc. Business Overview
      • 7.10.2 Cipla Inc. Transdermal Testosterone Quarterly Production and Revenue, 2020
      • 7.10.3 Cipla Inc. Transdermal Testosterone Product Introduction
      • 7.10.4 Cipla Inc. Response to COVID-19 and Related Developments

    8 Supply Chain and Sales Channels Analysis

    • 8.1 Transdermal Testosterone Supply Chain Analysis
      • 8.1.1 Transdermal Testosterone Supply Chain Analysis
      • 8.1.2 Covid-19 Impact on Transdermal Testosterone Supply Chain
    • 8.2 Distribution Channels Analysis
      • 8.2.1 Transdermal Testosterone Distribution Channels
      • 8.2.2 Covid-19 Impact on Transdermal Testosterone Distribution Channels
      • 8.2.3 Transdermal Testosterone Distributors
    • 8.3 Transdermal Testosterone Customers

    9 Key Findings

      10 Appendix

      • 10.1 About Us

      This report covers market size and forecasts of Transdermal Testosterone, including the following market information:
      Global Transdermal Testosterone Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
      Global Transdermal Testosterone Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
      Global Transdermal Testosterone Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
      Global Transdermal Testosterone Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K MT)

      Key market players
      Major competitors identified in this market include AbbVie, Teva, Perrigo, Endo Pharmaceuticals, Acerus Pharmaceuticals, Lupin, Dr. Reddy's Laboratories, Upsher-Smith Laboratories, Allergan, Cipla Inc., etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      Gel
      Patch
      Solution

      Based on the Application:
      Primary hypogonadism
      Hypogonadotropic hypogonadism
      Late-onset hypogonadism

      Buy now